Decision Memorandum CAG#-00438N entitled Transcatheter Mitral Valve Repair (TMVR) for Degenerative Mitral Regurgitation was published August 7, 2014. In this decision, CMS determined that it the evidence is sufficient to cover TMVR under Coverage with Evidence Development for Medicare beneficiaries under certain conditions only when the provider is participating in and patients are enrolled in a qualifying clinical studies meeting certain requirements. Consistent with section 1142 of the Social Security Act, the Agency for Healthcare Research and Quality (AHRQ) supports clinical research studies that the CMS determines meet specified standards and address the specified research questions.
The latest form for (CMS–10531) Transcatheter Mitral Valve Repair (TMVR) National Coverage Decision (NCD) (CMS-10531) expires 2021-12-31 and can be found here.
Document Name |
---|
Form and Instruction |
Form and Instruction |
Supporting Statement A |
Approved with change |
Revision of a currently approved collection | 2021-09-24 | |
Approved without change |
Reinstatement with change of a previously approved collection | 2018-07-18 | |
Approved with change |
New collection (Request for a new OMB Control Number) | 2015-03-18 |
Federal Enterprise Architecture: Health - Public Health Monitoring
Form CMS-10531 | TVT Registry | Fillable Fileable | Form and instruction |
Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.